Cognyte initiated with a Buy at Roth Capital

Roth Capital initiated coverage of Cognyte (CGNT) with a Buy rating and $14 price target The company is a leader in intelligence analytics, helping law enforcement and intelligence agencies analyze large volumes of data, the analyst tells investors in a research note. The firm says Cognyte’s growth is accelerating with margins moving higher. Almost half of Cognyte’s revenue is recurring, which creates good revenue visibility, adds Roth.